Literature DB >> 27931845

Immuno-oncology: Allying forces of radio- and immuno-therapy to enhance cancer cell killing.

Jacques Bernier1.   

Abstract

Besides the local effects of ionizing radiation at the cellular and molecular levels in tumor tissues, the interactions of radiotherapy with the host's immune system are nowadays at the center of many investigations. In some cases, these interactions can be strong enough to immunize the patient against the tumor, leading to a rejection by the host of both the irradiated tumor and distant metastases. In this latter case, the rejection mechanism is called "abscopal effect". Over the last two decades, increasing attention has also been paid to the combination of various forms of immunotherapies with radiation, as an attempt to boost cancer cell killing mechanisms. In particular, a significant number of translational and clinical studies are now investigating both the effects of immune checkpoint blockade strategies and adoptive immunotherapies in combination with radiation. A better understanding of the mechanisms driving the interactions between ionizing radiation and the immune system help us envision the advantages that may be offered by the adjunction of immunotherapy to radiotherapy in various clinical models. Copyright Â
© 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  CTLA-4; Immune activation; Immune checkpoints inhibitors; Immune system; Immunotherapy; PD-1; Radiation; Radiotherapy

Mesh:

Substances:

Year:  2016        PMID: 27931845     DOI: 10.1016/j.critrevonc.2016.11.001

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  5 in total

1.  Effects of Gamma and Electron Radiation on the Structural Integrity of Organic Molecules and Macromolecular Biomarkers Measured by Microarray Immunoassays and Their Astrobiological Implications.

Authors:  Yolanda Blanco; Graciela de Diego-Castilla; Daniel Viúdez-Moreiras; Erika Cavalcante-Silva; José Antonio Rodríguez-Manfredi; Alfonso F Davila; Christopher P McKay; Victor Parro
Journal:  Astrobiology       Date:  2018-08-02       Impact factor: 4.335

Review 2.  Pembrolizumab in cervical cancer: latest evidence and clinical usefulness.

Authors:  Edith Borcoman; Christophe Le Tourneau
Journal:  Ther Adv Med Oncol       Date:  2017-05-08       Impact factor: 8.168

3.  Tumors Resistant to Checkpoint Inhibitors Can Become Sensitive after Treatment with Vascular Disrupting Agents.

Authors:  Michael R Horsman; Thomas R Wittenborn; Patricia S Nielsen; Pernille B Elming
Journal:  Int J Mol Sci       Date:  2020-07-06       Impact factor: 5.923

4.  Abscopal Activation of Microglia in Embryonic Fish Brain Following Targeted Irradiation with Heavy-Ion Microbeam.

Authors:  Takako Yasuda; Miyuki Kamahori; Kento Nagata; Tomomi Watanabe-Asaka; Michiyo Suzuki; Tomoo Funayama; Hiroshi Mitani; Shoji Oda
Journal:  Int J Mol Sci       Date:  2017-07-04       Impact factor: 5.923

Review 5.  Theragnostic Aspects and Radioimmunotherapy in Pediatric Tumors.

Authors:  Andrea Cimini; Maria Ricci; Agostino Chiaravalloti; Luca Filippi; Orazio Schillaci
Journal:  Int J Mol Sci       Date:  2020-05-28       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.